332 related articles for article (PubMed ID: 12124804)
21. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
22. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
23. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
24. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.
Albuquerque C; Breukel C; van der Luijt R; Fidalgo P; Lage P; Slors FJ; Leitão CN; Fodde R; Smits R
Hum Mol Genet; 2002 Jun; 11(13):1549-60. PubMed ID: 12045208
[TBL] [Abstract][Full Text] [Related]
25. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
27. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
Chen YW; Jeng YM; Yeh SH; Chen PJ
Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
[TBL] [Abstract][Full Text] [Related]
28. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
[TBL] [Abstract][Full Text] [Related]
29. Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines.
Pollock PM; Hayward N
Melanoma Res; 2002 Apr; 12(2):183-6. PubMed ID: 11930117
[TBL] [Abstract][Full Text] [Related]
30. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
Abraham SC; Wu TT; Klimstra DS; Finn LS; Lee JH; Yeo CJ; Cameron JL; Hruban RH
Am J Pathol; 2001 Nov; 159(5):1619-27. PubMed ID: 11696422
[TBL] [Abstract][Full Text] [Related]
31. Stabilization of beta-catenin by genetic defects in melanoma cell lines.
Rubinfeld B; Robbins P; El-Gamil M; Albert I; Porfiri E; Polakis P
Science; 1997 Mar; 275(5307):1790-2. PubMed ID: 9065403
[TBL] [Abstract][Full Text] [Related]
32. Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma.
Siriwardena BS; Kudo Y; Ogawa I; Tilakaratne WM; Takata T
Oral Oncol; 2009 Feb; 45(2):103-8. PubMed ID: 18486530
[TBL] [Abstract][Full Text] [Related]
33. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
[TBL] [Abstract][Full Text] [Related]
34. Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions.
Gottardi CJ; Gumbiner BM
Am J Physiol Cell Physiol; 2004 Apr; 286(4):C747-56. PubMed ID: 14613891
[TBL] [Abstract][Full Text] [Related]
35. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
Mirabelli-Primdahl L; Gryfe R; Kim H; Millar A; Luceri C; Dale D; Holowaty E; Bapat B; Gallinger S; Redston M
Cancer Res; 1999 Jul; 59(14):3346-51. PubMed ID: 10416591
[TBL] [Abstract][Full Text] [Related]
36. Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.
Koppert LB; van der Velden AW; van de Wetering M; Abbou M; van den Ouweland AM; Tilanus HW; Wijnhoven BP; Dinjens WN
Br J Cancer; 2004 Feb; 90(4):892-9. PubMed ID: 14970870
[TBL] [Abstract][Full Text] [Related]
37. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
[TBL] [Abstract][Full Text] [Related]
38. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.
Abraham SC; Reynolds C; Lee JH; Montgomery EA; Baisden BL; Krasinskas AM; Wu TT
Hum Pathol; 2002 Jan; 33(1):39-46. PubMed ID: 11823972
[TBL] [Abstract][Full Text] [Related]
39. Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?
Gad S; Teboul D; Lièvre A; Goasguen N; Berger A; Beaune P; Laurent-Puig P
BMC Cancer; 2004 Jul; 4():31. PubMed ID: 15245581
[TBL] [Abstract][Full Text] [Related]
40. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis.
Aust DE; Terdiman JP; Willenbucher RF; Chang CG; Molinaro-Clark A; Baretton GB; Loehrs U; Waldman FM
Cancer; 2002 Mar; 94(5):1421-7. PubMed ID: 11920497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]